Síndrome metabólica em ambulatório cardiológico

Silva, Antônio Augusto Moura da; Barbosa, Fabrício de Flores; Júnior, Francisco das Chagas Monteiro; Neto, José Albuquerque de Figueiredo; Nina, Vinicius José da Silva; Ribeiro, Waston Gonçalves; Figueredo, Eduardo; Barbosa, José Bonifácio; Chein, Maria Bethânia da Costa

doi:10.1590/s0066-782x2010000100009

Cited by 10 publications

(9 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Barbosa et al evaluated an urban population. 25 In contrast, the Quilombola communities reported here are essentially rural. This may explain the difference in the identified prevalence of MS. Lifestyle and eating habits may contribute to these differences.…”

mentioning

confidence: 67%

See 1 more Smart Citation

Dyslipidemia and cardiovascular risk in Afro-descendants: a study of the Quilombola communities in Maranhão, Brazil

Barbosa¹,

Barbosa²,

Guerra³

et al. 2015

Rev Bras Med Fam Comunidade

Self Cite

View full text Add to dashboard Cite

Objective: to evaluate the prevalence of cardiovascular risk factors associated with dyslipidemia in Quilombola communities in Maranhão, Brazil. Methods: a cross-sectional study was performed from February 2010 to November 2011. A total of 202 individuals belonging to the Quilombola communities in Codó, Maranhão were assessed. Risk factors associated with dyslipidemia and metabolic syndrome (MS) were evaluated. Results: the results showed a high prevalence of dyslipidemia (72.28%) and hypertension (43.07%). Isolated hypertriglyceridemia (38.61%) with normal levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol was present in most individuals. Furthermore, the prevalence of MS and the estimated cardiovascular risks were low in this population. Conclusion: dyslipidemia, at the expense of triglycerides, and hypertension was highly prevalent. However, the frequency of other risk factors for cardiovascular events was low. A low prevalence of MS and cardiovascular risk according to the Framingham score for cardiovascular diseases was also identified.

show abstract

mentioning

confidence: 67%

“…The prevalence was higher among individuals with low income and advanced age. 25 The study sample had a different sociodemographic profile than that in our study. Barbosa et al evaluated an urban population.…”

mentioning

confidence: 74%

Dyslipidemia and cardiovascular risk in Afro-descendants: a study of the Quilombola communities in Maranhão, Brazil

Barbosa¹,

Barbosa²,

Guerra³

et al. 2015

Rev Bras Med Fam Comunidade

Self Cite

View full text Add to dashboard Cite

show abstract

“…Ambulatório de Cardiologia em São Luiz (MA) (63,6%; n=457) 13 Quanto aos critérios da SM, nosso estudo obteve maior prevalência de obesidade abdominal (60,1%; n=146), HAS (50,6%; n=123) e HDL-colesterol baixo (48,1%; n=117), concordando com um estudo realizado no Rio de Janeiro 25 e EUA 16 . A menor ocorrência de hiperglicemia (29,6%) e hipertrigliceridemia (28,4%) concordam com um estudo realizado no semiárido Baiano, sugerindo que a elevação dos níveis pressóricos seja a primeira alteração ocasionada pelo quadro de excesso de gordura abdominal 26 .…”

Section: Discussionunclassified

“…Nos homens o HDL-colesterol baixo prevaleceu, seguido de HAS e hiperinsulinemia, onde os níveis de HDL-C abaixo de 40mg/dL tem estado associado com doença cardiovascular prematura e com elevação do risco de infarto do miocárdio 11,13 .…”

Section: Discussionunclassified

Prevalência De Síndrome Metabólica No Município De Ouro Verde, Santa Catarina

Dambroso

Moretti

et al. 2016

View full text Add to dashboard Cite

ResumoIntrodução: A Síndrome Metabólica é um transtorno representado por um conjunto de fatores de risco cardiovasculares, tais como hipertensão arterial, deposição central de gordura, dislipidemia (triglicerídeos elevados e HDL-colesterol reduzido) e resistência à insulina. Esses fatores promovem de forma direta o desenvolvimento de doenças cardiovasculares, que é considerado o principal problema de saúde pública no mundo. AbstractBackground: Metabolic syndrome is a disorder represented by a set of cardiovascular risk

show abstract

“…A síndrome aumenta com a idade, em homens e mulheres, alcançando 50% entre 60 e 69 anos (BARBOSA et al, 2010). Não foram encontrados estudos sobre a prevalência da SM com dados representativos da população brasileira.…”

Section: Definição De Síndrome Metabólicaunclassified

Efeitos De Um Programa De Caminhada Supervisionada Na Qualidade De Vida De Indivíduos Com Síndrome Metabólica

Santos¹,

Silva

Silva³

2011

RevistaUnivap

View full text Add to dashboard Cite

RESUMO: A realização de exercício físico regular é a terapia não-medicamentosa de primeira escolha para tratamento de indivíduos com Síndrome Metabólica (SM), ABSTRACT: Regular exercise is the first choice of a non-drug therapy to treat patients with metabolic syndrome, because it reduces weight, improves insulin sensitivity, decreases glucose levels, prevents the onset of diabetes, and improves the quality of life (QL). The aim of this study was to evaluate the benefits of a supervised walking program (SWP) on the QL of individuals with metabolic syndrome. Eight volunteers with metabolic syndrome (63 ± 9.65 years)

show abstract

Síndrome metabólica em ambulatório cardiológico

Abstract: Background: In Brazil, the prevalence of the metabolic syndrome (MS) is little known in several regions.

Cited by 10 publications

References 21 publications

Dyslipidemia and cardiovascular risk in Afro-descendants: a study of the Quilombola communities in Maranhão, Brazil

Dyslipidemia and cardiovascular risk in Afro-descendants: a study of the Quilombola communities in Maranhão, Brazil

Prevalência De Síndrome Metabólica No Município De Ouro Verde, Santa Catarina

Efeitos De Um Programa De Caminhada Supervisionada Na Qualidade De Vida De Indivíduos Com Síndrome Metabólica

Contact Info

Product

Resources

About